Mandate

Vinge advises eEducation Albert AB (publ) in connection with the listing on Nasdaq First North Growth Market6 October 2021

Vinge has advised eEducation Albert AB (publ) (”Albert”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 21 September 2021 and the first day of trading occurred on 1 October 2021.

The offer in connection with the listing covered approximately 4 700 000 newly issued shares as well as an oversubscription option for a further total amount of approximately 700 000 shares. The shares were offered at a price of SEK 49 per share, which entails that the offer (in conjunction with full utilization of the oversubscription option) amounted to approximately SEK 264 million. The price corresponds to a market value for the company of approximately SEK 600 million prior to the implementation of the offer.

Albert, which was founded in 2015 and has its registered office in Gothenburg, is an app‑based educational platform for children in the age intervals between 3 and 16 and offers EdTech services on a subscription basis. Since Albert was founded, the company has helped more than 275 000 families with their children’s education.

Vinge’s team primarily consisted of Wibeke SorlingEdin AgicLinus AdolfssonHanna Jansson (Capital Markets and Public M&A), Anna Backman (Employment), Alexander LindbergAnna Högsten (IP/IT), Victor Ericsson and Emelie Svanberg (Tax).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025